REPORTS

Let’s Pullulate and Expand Your Business

Arthritis Drug Market - Global Professional Analysis and Forecast to 2026

Feb 14, 2020  |  195 PAGES  |  REPORT CODE: CMM266798
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Arthritis Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the Arthritis Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Arthritis Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Arthritis Drug industry and will help you to build a panoramic view of the industrial development.

Arthritis Drug Market, By Type:

  • Synthetic DMARDs

  • Biological DMARDs

  • NSAIDs

  • Corticosteroids

  • Analgesics

Arthritis Drug Market, By Application:

  • Retail Pharmacies

  • Hospital Pharmacies

  • Drug Stores

  • E-Commerce

Some of the leading players are as follows:

  • Johnson & Johnson

  • Celltrion

  • Novartis

  • GSK

  • Pfizer

  • Eli Lilly

  • F. Hoffmann-La Roche

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Arthritis Drug Market: Technology Type Analysis

  • 4.1 Arthritis Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Arthritis Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Synthetic DMARDs

    • 4.3.2 Biological DMARDs

    • 4.3.3 NSAIDs

    • 4.3.4 Corticosteroids

    • 4.3.5 Analgesics

5 Arthritis Drug Market: Product Analysis

  • 5.1 Arthritis Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Arthritis Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Arthritis Drug Market: Application Analysis

  • 6.1 Arthritis Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Arthritis Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Retail Pharmacies

    • 6.3.2 Hospital Pharmacies

    • 6.3.3 Drug Stores

    • 6.3.4 E-Commerce

7 Arthritis Drug Market: Regional Analysis

  • 7.1 Arthritis Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Arthritis Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Johnson & Johnson

    • 9.1.1 Johnson & Johnson Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Celltrion

    • 9.2.1 Celltrion Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 GSK

    • 9.4.1 GSK Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Pfizer

    • 9.5.1 Pfizer Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Eli Lilly

    • 9.6.1 Eli Lilly Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 F. Hoffmann-La Roche

    • 9.7.1 F. Hoffmann-La Roche Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

 

The List of Tables and Figures (Totals 88 Figures and 136 Tables)

  • Figure Synthetic DMARDs Arthritis Drug market, 2015 - 2026 (USD Million)

  • Figure Biological DMARDs Arthritis Drug market, 2015 - 2026 (USD Million)

  • Figure NSAIDs Arthritis Drug market, 2015 - 2026 (USD Million)

  • Figure Corticosteroids Arthritis Drug market, 2015 - 2026 (USD Million)

  • Figure Analgesics Arthritis Drug market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Drug Stores market, 2015 - 2026 (USD Million)

  • Figure E-Commerce market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Arthritis Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Arthritis Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Arthritis Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Arthritis Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Arthritis Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Arthritis Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Arthritis Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Arthritis Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Celltrion Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top